1. Bystron, I, Blakemore, C, Rakic, P. Development of the human cerebral cortex: Boulder Committee revisited. Nat Rev Neurosci 2008; 9: 110–122.
Google Scholar | Crossref | Medline | ISI2. Barkovich, AJ, Dobyns, WB, Guerrini, R. Malformations of cortical development and epilepsy. Cold Spring Harb Perspect Med 2015; 5: a022392.
Google Scholar | Crossref | Medline3. Frater, JL, Prayson, RA, Morris, HH, et al. Surgical pathologic findings of extratemporal-based intractable epilepsy: a study of 133 consecutive resections. Arch Pathol Lab Med 2000; 124: 545–549.
Google Scholar | Crossref | Medline4. Pasquier, B, Péoc’H, M, Fabre-Bocquentin, B, et al. Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections. Epileptic Disord 2002; 4: 99–119.
Google Scholar | Medline | ISI5. Blumcke, I . Neuropathology of focal epilepsies: a critical review. Epilepsy Behav 2009; 15: 34–39.
Google Scholar | Crossref | Medline | ISI6. Harvey, AS, Mandelstam, SA, Maixner, WJ, et al. The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasia. Neurology 2015; 84: 2021–2028.
Google Scholar | Crossref | Medline7. Jin, B, Wang, J, Zhou, J, et al. A longitudinal study of surgical outcome of pharmacoresistant epilepsy caused by focal cortical dysplasia. J Neurol 2016; 263: 2403–2410.
Google Scholar | Crossref | Medline8. Maynard, LM, Leach, JL, Horn, PS, et al. Epilepsy prevalence and severity predictors in MRI-identified focal cortical dysplasia. Epilepsy Res 2017; 132: 41–49.
Google Scholar | Crossref | Medline9. Guerrini, R, Dobyns, WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol 2014; 13: 710–726.
Google Scholar | Crossref | Medline | ISI10. Guye, M, Bartolomei, F, Ranjeva, JP. Malformations of cortical development: the role of 7-Tesla magnetic resonance imaging in diagnosis. Rev Neurol 2019; 175: 157–162.
Google Scholar | Crossref | Medline11. Wang, ZI, Alexopoulos, AV, Jones, SE, et al. Linking MRI postprocessing with magnetic source imaging in MRI-negative epilepsy. Ann Neurol 2014; 75: 759–770.
Google Scholar | Crossref | Medline12. Jin, B, Krishnan, B, Adler, S, et al. Automated detection of focal cortical dysplasia type II with surface-based magnetic resonance imaging postprocessing and machine learning. Epilepsia 2018; 59: 982–992.
Google Scholar | Crossref | Medline13. Lerner, JT, Salamon, N, Hauptman, JS, et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009; 50: 1310–1335.
Google Scholar | Crossref | Medline | ISI14. O’Donoghue, MF, Duncan, JS, Sander, JW. The subjective handicap of epilepsy. A new approach to measuring treatment outcome. Brain 1998; 121: 317–343.
Google Scholar | Crossref | Medline15. Fisher, RS, Cross, JH, French, JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 522–530.
Google Scholar | Crossref | Medline16. Barkovich, AJ, Guerrini, R, Kuzniecky, RI, et al. A developmental and genetic classification for malformations of cortical development: update 2012. Brain 2012; 135: 1348–1369.
Google Scholar | Crossref | Medline | ISI17. Blumcke, I, Thom, M, Aronica, E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52: 158–174.
Google Scholar | Crossref | Medline | ISI18. Wang, S, Jin, B, Aung, T, et al. Application of MRI post-processing in presurgical evaluation of non-lesional cingulate epilepsy. Front Neurol 2018; 9: 1013.
Google Scholar | Crossref19. Ding, Y, Zhu, Y, Jiang, B, et al. (18)F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy. Eur J Nucl Med Mol Imaging 2018; 45: 1567–1572.
Google Scholar | Crossref | Medline20. Barkovich, AJ, Kuzniecky, RI, Bollen, AW, et al. Focal transmantle dysplasia: a specific malformation of cortical development. Neurology 1997; 49: 1148–1152.
Google Scholar | Crossref | Medline21. Stutterd, CA, Leventer, RJ. Polymicrogyria: a common and heterogeneous malformation of cortical development. Am J Med Genet C Semin Med Genet 2014; 166C: 227–239.
Google Scholar | Crossref | Medline22. Stephen, LJ, Brodie, MJ. Selection of antiepileptic drugs in adults. Neurol Clin 2009; 27: 967–992.
Google Scholar | Crossref | Medline23. Brodie, MJ, Barry, SJ, Bamagous, GA, et al. Patterns of treatment response in newly diagnosed epilepsy. Neurology 2012; 78: 1548–1554.
Google Scholar | Crossref | Medline | ISI24. Chi, X, Li, R, Hao, X, et al. Response to treatment schedules after the first antiepileptic drug failed. Epilepsia 2018; 59: 2118–2124.
Google Scholar | Crossref | Medline25. Berg, AT, Shinnar, S, Levy, SR, et al. Early development of intractable epilepsy in children: a prospective study. Neurology 2001; 56: 1445–1452.
Google Scholar | Crossref | Medline | ISI26. Perucca, P, Mula, M. Antiepileptic drug effects on mood and behavior: molecular targets. Epilepsy Behav 2013; 26: 440–449.
Google Scholar | Crossref | Medline27. Abou-Khalil, B . Selecting rational drug combinations in epilepsy. CNS Drugs 2017; 31: 835–844.
Google Scholar | Crossref | Medline28. Kwan, P, Arzimanoglou, A, Berg, AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069–1077.
Google Scholar | Crossref | Medline | ISI29. Kwan, P, Brodie, MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314–319.
Google Scholar | Crossref | Medline | ISI30. Sillanpaa, M, Schmidt, D. Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. Brain 2009; 132: 989–998.
Google Scholar | Crossref | Medline31. Weijenberg, A, Brouwer, OF, Callenbach, PM. Levetiracetam monotherapy in children with epilepsy: a systematic review. CNS Drugs 2015; 29: 371–382.
Google Scholar | Crossref | Medline32. Fois, C, Rassu, AL, Mandia, D, et al. Paradoxical effect of levetiracetam in newly diagnosed type II focal cortical dysplasia. Clin Neuropharmacol 2016; 39: 265–268.
Google Scholar | Crossref | Medline33. Cvetkovska, E, Kuzmanovski, I, Babunovska, M, et al. Levetiracetam-induced seizure aggravation in patients with focal cortical dysplasia. Clin Neuropharmacol 2018; 41: 218–221.
Google Scholar | Crossref | Medline34. Feyissa, AM, Lopez Chiriboga, AS, Britton, JW. Antiepileptic drug therapy in patients with autoimmune epilepsy. Neurol Neuroimmunol Neuroinflamm 2017; 4: e353.
Google Scholar | Crossref | Medline35. Eddy, CM, Rickards, HE, Cavanna, AE. The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord 2011; 4: 385–407.
Google Scholar | SAGE Journals36. Strozzi, I, Nolan, SJ, Sperling, MR, et al. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev 2015; 2: CD001902.
Google Scholar37. Wang, X, He, R, Zheng, R, et al. Relative seizure relapse risks associated with antiepileptic drug withdrawal after different seizure-free periods in adults with focal epilepsy: a prospective, controlled follow-up study. CNS Drugs 2019; 33: 1121–1132.
Google Scholar | Crossref | Medline